Sleep disorders are highly prevalent during late pregnancy and can impose adverse effects such as pre-eclampsia and diabetes. However, the consequences of fragmented sleep (SF) on offspring metabolism and epigenomic signatures are unclear. We report that physical activity during early life, but not later, reversed the increased body weight, altered glucose and lipid homeostasis, and increased visceral adipose tissue in offspring of mice subjected to gestational SF (SFo). The reversibility of this phenotype may reflect epigenetic mechanisms induced by SF during gestation. Accordingly, we found that the metabolic master switch Foxo1 was epigenetically misregulated in SFo livers in a temporally-regulated fashion. Temporal Foxo1 analysis and its gluconeogenetic targets revealed that the epigenetic abnormalities of Foxo1 precede the metabolic syndrome phenotype. Importantly, regular physical activity early, but not later in life, reversed Foxo1 epigenetic misregulation and altered the metabolic phenotype in gestationally SF-exposed offspring. Thus, we have identified a restricted post-natal period during which lifestyle interventions may reverse the Foxo1 epigenetically-mediated risk for metabolic dysfunction later in the life, as induced by gestational sleep disorders.
INTRODUCTION
The term "epigenetics", refers to DNA and histone modifications and noncoding RNA, which result in heritable changes in gene expression among the next generation without a change in the DNA sequence (5, 17, 29) . The environment, such as diet and early life experiences, can influence the epigenome. Epigenetic abnormalities have been found to be causative factors in cancer, as well as contributing factors in autoimmune diseases, metabolic pathways and aging.
Disruption of the balance of epigenetic networks can lead to inappropriately heightened expression or silencing of genes, resulting in "epigenetic diseases". In contrast to genetic events, the potential reversibility of epigenetic states offers exciting opportunities for new therapeutic targets (9, 19) .
Sleep disorders are highly prevalent among women during late gestation, and are characterized by increased awakenings during the night and sleep maintenance insomnia, which are potentially fraught with adverse pregnancy outcomes (13, 21, 38, 45) . Among the disorders that impose additional disruption of sleep integrity during pregnancy, sleep-disordered breathing (SDB) is particularly prevalent, and has emerged as a contributor to gestational diabetes mellitus, pre-eclampsia, as well as to adverse perinatal outcomes (28, 42) . However, the impact of poor sleep quality and continuity during pregnancy could transcend the gestational period and adversely affect children even late in life (7) . Sleep disorders in adults are associated with insulin resistance, glucose intolerance, and type 2 diabetes (52). Although a multiplicity of gestational exposures during late pregnancy are associated with an increased risk of chronic diseases in the offspring, (27) little is known about the possible consequences of late pregnancy sleep disruption on offspring metabolic function. We address this question in a murine model of gestational sleep disturbance (23) and hypothesize that excessive sleep fragmentation (SF) induces misregulation of metabolic genes in the offspring by epigenetic mechanisms, which may contribute to the "metabolic syndrome" (MetS) during adulthood. We further posited that such changes are potentially reversible by increased physical activity implemented during a selective temporallyrestricted developmental window.
We focused on Foxo1 (Forkhead box O1) gene, which has been identified as a transcription factor that plays critically important roles in the regulation of gluconeogenesis and glycogenolysis by insulin signaling (47) in liver. Indeed, dysregulation of FOXO1 function has been implicated in diabetes (51) and insulin resistance. In the insulin-resistant murine model, there is increased hepatic glucose production due to a loss of insulin sensitivity and this is presumably due to un-regulated FOXO1 (1) . Our epigenetic analyses demonstrate that active epigenetic marks are significantly elevated and inactive marks decreased at the Foxo1 promoter and at the putative regulatory regions upstream of the gene transcription start site (TSS) in SFo compared to control offspring (SCo). This epigenetic signature correlated in a temporally regulated fashion with increased Foxo1 expression and elevated levels of its known gluconeogenesis gene targets. Importantly, the epigenetic changes in the Foxo1 were reversed by implementation of physical activity during early, but not later in life in the offspring. Such reversibility correlated with abrogation of the adverse metabolic consequences imposed on the offspring by excessive sleep perturbation in the mother. Figure 1 .
MATERIALS AND METHODS

Animals
Sleep fragmentation and physical activity. The sleep fragmentation device used to induce SF in rodents has been previously described (23, 36, 41) and employs intermittent tactile stimulation of freely behaving mice in a standard laboratory mouse cage, using a near-silent motorized mechanical sweeper. To induce moderate to severe sleep fragmentation, we chose a 2-min interval between each sweep, implemented during the light period (7 a.m.to 7 p.m.). This paradigm is not associated with any increases in the plasma levels of the stress hormones (36, 41) . Pregnant mice were fragmented from day 14 till day 19 of gestation. PA was induced as previously described (16) using a motorized forced exercise/walking wheel system for mice (Lafayette Instruments, Lafayette, IN). The PA groups were exposed to the walking wheeled system for 30 min., 3 times per week whereas the control groups were placed in the wheeled system and remained in the immobile apparatus for the same period of time. Early PA was implemented between 4-8 weeks of age and late PA between 16-20 weeks of age.
Body Weight and Food Intake: Body weight was assessed weekly for a period of 24 weeks always at the same time of the day (middle of the light cycle period). Food intake was carefully recorded daily for each cage starting at week 5 after birth.
GTT and ITT:
Both tests were performed at week 24 after birth in a random order, except in a selected subset of mice undergoing late PA exposures that were tested at both 20 and 24 weeks.
In both tests, animals were fasted for 3 hours with water available ad libitum. Biochemical analyses: Blood samples were centrifuged at 2000 × g for 20 min at 4°C, subsequently plasma was centrifuged for 5 minutes at 15,000 g, and immediately frozen at -80°C until further analysis. Lipid profiles, including total cholesterol, and triglycerides (TG) were measured in plasma using Infinity kits (Thermo Scientific).
Gene-specific analysis of differential DNA 5-methyl-CpG and 5-hydroxymethyl-CpG.
Methylated DNA ImmunoPrecipitation (MeDIP) was performed as previously described (33) .
Genomic DNA was sonicated to produce random fragments ranging in size from 200 to 1,000 bp. Denatured DNA was immunoprecipitated with antibody against 5-methylcytidine or with 5-hydroxymethyl-CpG antibody. Sonicated input DNA and immunoprecipitated DNA was analyzed by regular Q-PCR, using specific primers at the region of interest.
Gene-specific analyses of histone modifications. Crosslinking with formaldehyde was performed, which allowed shearing of chromatin into small-sized fragments after sonication of the crosslinked samples (chromatin fragments ranging in size from 200 to 500 bp.)
Immunoprecipitation of chromatin fragments with antibodies specific for different histone modifications (Table 1 ) was performed as previously described (35) . Purified input and immunoprecipitated DNA were amplified, and analyzed by regular Q-PCR, using specific primers at the region of interest (Table 1) .
Comparative gene expression analysis. Total RNA from the samples was isolated and reverse transcribed. cDNA products were amplified by real-time PCR using specific primers (Table 1) .
Quantitative real-time PCR data analysis. DNA samples from input (In) and antibody-bound Statistical analyses. Statistical analyses were conducted using SPSS software (version 18;
Chicago, IL, USA), and consisted of either two-way analysis of variance for repeated measures followed by post hoc Bonferroni corrections or unpaired t-tests as appropriate. A two-tailed Pvalue<0.05 was considered statistically significant.
RESULTS
Physical activity during early life in SF offspring, but not during late life, reverses metabolic dysfunction induce by late pregnancy sleep perturbations.
To investigate the consequences of SF during late gestation on metabolism and epigenetics of the offspring, pregnant mice were exposed to a SF paradigm during daylight hours (awakenings from sleep were implemented every 2-min) from day 14 until day 19 of gestation ( The reversibility of the SFo metabolic phenotype suggests an epigenetic mechanism.
Epigenetic events play a significant role in enabling the gestational environment to influence the developmental trajectory through modulation of gene expression (5, 17, 29) . Sleep disorders may interfere with the normal development of metabolic processes in organs such as liver through epigenetic programing, and potentially promote the development of metabolic diseases in modern society (15, 31, 49) . We hypothesized that epigenetically-driven changes in expression of master regulators of metabolic pathways, such as Foxo1, may partially contribute to the altered metabolic phenotype in SFo mice. FOXO1 is a transcription factor that plays critical roles in the regulation of gluconeogenesis and glycogenolysis by insulin signaling in the liver (26, 47, 51) . Mechanisms governing FOXO1 regulation by posttranscriptional protein modifications have been extensively studied. However, Foxo1regulation at the level of transcription, including chromatin modifications and presence of any Foxo1 regulatory elements remains virtually unexplored. We assessed previously known epigenetic modifications involved in gene regulation: like histone modifications and DNA methylation marks by ChIP and MeDIP analysis, respectively applying our previously developed approach for single gene epigenetic analysis (33, 35) . We first validated this approach in both SCo and SFo using mouse livers samples (Fig.5 ).
For precise estimation of specific gene enrichment or depletion of each chromatin mark in both SCo and SFo samples we performed a normalization procedure of our data based on the presence of these individual epigenetic marks in the Tbp gene, since neither its epigenetic state nor its expression were affected by SF or by physical activity intervention ( data not shown).
We profiled the epigenetic landscape of the Foxo1 locus (Fig. 6A-G (Fig. 6D ). We did not find any significant epigenetic differences between SCo and SFo in two control genes:
Actb and Fscn2, but observed significant epigenetic differences that were inversely correlated with the Foxo1 epigenetic marks in another control gene: Gapdh (Fig. 6A-D) . These results further confirmed the validity of our epigenetic analyses in SCo and SFo samples. Taken together, these observations support the presence of specific epigenetic signatures in the offspring of pregnant mice subjected to late gestational SF. Moreover, epigenetic modifications in a region approximately 2kb upstream of the Foxo1 transcription start site (TSS) suggested the presence of a putative enhancer ( Fig. 6E-H ) that was preferentially active in SFo compared to SCo ( Fig. 6A-G) . Publicly available human and mouse ChIP-Seq data from ENCODE used for genome-wide identification of enhancers confirmed that this region has chromatin characteristics of an enhancer, namely is enriched in histone H3K4 monomethylation and depleted in histone H3K4 trimethylation (Fig. 6H) . The importance of enhancer elements during development provides an indication that their deregulation, including epigenetic misregulation, is likely to impose phenotypic consequences (6, 10, 44) . Interestingly, the epigenetic marks in this locus significantly differed between SFo and SCo. We found an increase of 5-hydroxy methyl-CpG (Fig. 6C) , which was recently suggested to take part in the function of activated enhancers (40) .
In addition, by performing ChIP analysis we observed slight increases of histone H3K4m3 (Fig.   6B ), as well as histone modifications ratios of H3K4m3 (active mark)/H3K4m1 (enhancer mark) and H3K27m3 (inactive mark)/H3K4m1 (enhancer mark) (Fig. 6E, F ) that were specific for SFo and not present in SCo at this Foxo1 putative enhancer locus. Finally, we performed ChIP analyses in SCo and SFo with an antibody specific to histone H3K27 acetylation, a histone mark associated with activated gene enhancers (39), and observed an enrichment at the putative Foxo1 enhancer locus in SFo livers (Fig. 6G ). This chromatin signature has been previously implicated as a switch from "poised" to "active" genome enhancers (39).
The increases in transcriptionally active epigenetic marks at the Foxo1 locus were correlated with increased expression of the Foxo1 in SFo (Fig. 7) . Similar correlations were observed with some of the known Foxo1 target gluconeogenesis genes (48) (Pck1, Pdk4) and its co-activator in gluconeogenesis genes transcription Pgc-1α, but not control genes (Actb, Fto). However, Gapdh, which exhibited decreases in active epigenetic marks in SFo ( Fig. 6A-C) , showed significantly decreased levels of its expression in SFo compared to SCo (Fig. 7) .
The epigenetic abnormalities in the Foxo1 affect the putative regulatory element in early post-natal life, but not the Foxo1 promoter or expression.
To delineate the temporal window during which the aforementioned abnormal states may develop, a time-course analysis of the epigenetic landscape and expression of Foxo1 following gestational SF were assessed (Fig. 8A-D) . We analyzed the presence of histone H3 acetylation, usually distributed at both gene promoters and enhancers (44) and histone H3 trimethylation mostly enriched at gene TSS (44) . We found that during early life stages (3 weeks after birth) of SFo offspring, epigenetic differences between SFo and SCo mice at the Foxo1 locus are restricted to the putative regulatory element (Fig. 9A, C) , but are not detectable within the gene promoter (Fig. 8B, D) , nor do they affect the level of Foxo1 expression or one of its primary targets Pdk4 (Fig. 8E, F) . The first significant differences between SCo and SFo in the epigenetic abnormalities at Foxo1 promoter and putative enhancer as well as its gene expression appeared at post-natal age of 8 weeks (Fig. 8A-E) . Importantly, these results indicate that the epigenetic abnormalities at Foxo1 in SFo occur in a temporally-regulated fashion and precede the metabolic syndrome phenotype, which develops on later in life around weeks 20-24 post-natally ( Fig. 2A-E) (23) .
To further explore specific chromatin modifications at the Foxo1 in livers of SFo mice,
we assessed whether the expression of some of the major epigenetic modifying enzymes are altered. We took advantage of a commercially available array that enables concurrent analyses of 84 genes epigenetic modifying enzymes, and found at least 6 enzymes that are differentially expressed in SFo compared to SCo (Fig. 9) . Although the direct implications of these observations to Foxo1 and to phenotype in SFo remain unclear, they reinforce however the concept that SF during late gestation imposes specific epigenetic alterations in the offspring.
These findings may serve as guides for future mechanistic exploration of the function of these 6 chromatin modifying enzymes in the metabolic dysfunction induced by gestational sleep disturbance. (Fig. 1) . Early ( Fig. 10A-D) , but not late PA (Fig. 10F) , abrogated SF-induced epigenetic changes reported above. The epigenetic effect of PA on Foxo1 was specific for SFo (the control gene Actb showed the same changes in both SCo and SFo epigenetic and gene expression analysis (Fig. 11A- 
Physical activity during early life in SF offspring
C). Foxo1 expression showed that early PA results in reductions in
Foxo1 expression in SFo to levels similar to SCo (Fig. 10E) , and that such reductions correlate with parallel decreases in FOXO1 downstream regulated genes (Pck1, Pdk4) and Pgc-1α, but not with control genes (Fto, Actb). However, no significant decreases in Foxo1 expression emerged after late PA (Fig. 10G ) and the reversal of the epigenetic modifications also failed to occur following late PA (Fig. 10F ). Most importantly, SFo Foxo1 reversal epigenetic signature by PA during early life was correlated with the disappearance of the MetS phenotype in SFo ( Fig. 4A-D) . Thus, early life interventions such as regular physical activity during a developmentally favorable window may reverse epigenetic modifications incurred during pregnancy in the context of perturbed sleep.
DISCUSSION
There is increasing evidence that chronic diseases like type 2 diabetes and heart disease might originate during early life, and our previous (23) and current studies illustrate how sleep perturbations may contribute to such processes. Developmental plasticity can be viewed as the ability of one genotype to produce a range of phenotypes in response to environmental conditions (4, 14) . Epigenetic processes represent major regulatory mechanisms by which the environment modulates gene transcription during development, and may account for decreased cellular plasticity through establishment of cell-specific epigenetic profiles during development (2) . The complexity of histone modifications, specifically whether they constitute as a "code" Epigenetic abnormalities can be reversed by specific interventions such as treatment with epigenetic drugs, nutrition, maternal care, or exercise (3, 9, 19, 43) . Our data show for the first time that the epigenetic abnormalities in the Foxo1 in the SFo offspring, as well as the MetS-like phenotype induced by SF during late gestation were reversed by instituting physical activity, but only when such physical activity was applied during early post-natal life. In addition to the already described function of the DNA methylation in PA effects, (3, 43) we showed that PA early can also reverse changes in other epigenetic modifications involved in Foxo1 regulation, namely DNA 5-hydroxymethyl-CpG and histone modifications (Fig. 11A, C, D) . Institution of PA at later stages of development did not elicit changes in Foxo1 expression and epigenetic marks and also failed to reverse the MetS phenotype (Fig. 4A-DB) . DNA hydroxymethylation (5-hmC), which we studied, is a novel epigenetic mark, hydroxylated from 5-mC by TET enzymes. Recent studies have indicated that 5-hmC can act not only as an intermediate to induce 5-mC demethylation, but also that these epigenetic marks contribute to gene expression (30, 53) and to biological processes such as tumorigenesis (32) . Tet1 and Tet2 double-knockout mice showed reduced 5hmC, increased 5mC levels, abnormal methylation at various imprinted loci and animals of both sexes were fertile (8) . A role for 5hmC as an epigenetic mark distinct from 5mC
has also been proposed (12) . Our work demonstrates that 5hmC is involved in the regulation of an important metabolic regulator gene, Foxo1.
Taken together, our findings unravel the epigenetically-mediated impact of altered gestational sleep on metabolic regulation in the offspring, illustrate a complex epigenetic signature in the Foxo1, a key metabolic regulator, and provide strong incentive for early detection of such sleep perturbations by identifying a restricted post-natal period during which lifestyle interventions such as physical activity may successfully reverse the risk for MetS later in life (see schematic diagram as shown in Fig. 12 ).
Perspectives and Significance
A high prevalence of fragmented sleep occurs during late pregnancy and is associated with adverse outcomes. Here, we show that gestational sleep perturbations induce misregulation of 
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